PACIRA BIOSCIENCES, INC. (NASDAQ: PCRX) – Alvarez v. Pacira BioSciences, et al., 2:25-cv-00322, (January 13, 2025, D.N.J.)
A federal securities class action has been filed on behalf of investors that purchased, or otherwise acquired, Pacira BioSciences securities between August 2, 2023 and August 8, 2024, inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ alleged violations of the federal securities laws.
Learn more about this case by clicking Pacira BioSciences complaint.
If you own PCRX stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire. All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.
SEND US A MESSAGE
Contact Us
ADDRESS
Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103